A New Analysis Says Collagen Supplement Studies Don't Add Up

Oral collagen supplements are sold on the promise that swallowing hydrolyzed collagen peptides will smooth wrinkles, plump skin and boost elasticity, claims typically backed by references to meta-analyses that pool results across dozens of clinical trials. A paper published in the October 2026 issue of the Journal of Cosmetic Dermatology takes those meta-analyses apart, and finds the underlying arithmetic does not hold up.

The authors, David Robert Grimes and Anjali Mahto, went back to the two major existing meta-analyses on oral collagen supplementation and checked their work against the primary studies each one cited. According to the paper's abstract, they found inaccurate reporting of data from primary studies and inappropriate combinations of measures likely to give rise to spurious results.

That second problem is a formulation-science issue as much as a statistical one. Trials measuring collagen's effect on skin aging use different instruments and different endpoints, including calipers or imaging systems for wrinkle depth, corneometry for hydration, and cutometry for elasticity, each on its own scale and with its own error margins. Pooling those disparate measurements into a single combined effect size, the kind of number that ends up in a marketing brochure as one tidy percentage improvement, requires that the underlying measures be statistically comparable. Grimes and Mahto's re-analysis concludes they were not.

Beyond auditing the two meta-analyses, the researchers ran their own meta-regression of the constituent collagen studies, this time accounting for cumulative dose, since trials have used widely varying amounts of collagen peptides over widely varying durations. That dose-adjusted analysis, described in the paper as accounting for dose variations in primary studies, found no evidence of benefit from collagen supplementation.

The gap between that conclusion and the confident claims already circulating in skincare marketing is the paper's central point. As the authors put it in their conclusion, in sharp contrast to the reported results from prior meta-analysis, this investigation does not find evidence of benefit for supplementation from existing collagen studies. They close by calling for evidence synthesis in this field to have a stronger methodological underpinning if results are to be clinically relevant, a modest-sounding ask that, if followed, would mean retiring some of the numbers currently used to sell collagen powders and gummies.